Can a 10-week online program help people with depression and schizophrenia get out more?
NCT ID NCT06336616
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a behavioral program called SWITCH that teaches people with serious mental illness (like depression, schizophrenia, or bipolar disorder) to set goals, use rewards, and build habits to do more activities outside the home. 52 participants will attend weekly online sessions for 10 weeks, then monthly sessions for 3 months. Researchers will track their activity, mood, and GPS location to see if the program helps them participate more in their community.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Behavioral activation program (SWITCH)
- What this could lead to
- If it works, this could point toward a simple, non-drug way to help people with serious mental illness feel more engaged and active in their communities.
- What could go wrong
- This is a small, early study with no control group, so results may not be generalizable. The intervention requires internet access and willingness to carry a GPS phone, which may limit who can participate.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BIPOLAR DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Temple University
Philadelphia, Pennsylvania, 19120, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new pill for schizophrenia pass its first human test?
- Can a structured care pathway ease teen depression?
- Can a nasal spray break through tough depression?
- Could a new drug offer hope for Treatment-Resistant depression?
- Can a new daily pill offer safer Long-Term control of schizophrenia?
- Targeting depression: can MRI-Guided brain zaps rewire key circuits?